FDA receives more than 9,000 malfunction reports with blood testing devices
Since 2002, the FDA has received more than 9,000 reports of malfunctions with the INRatio and INRatio2 blood testing devices, the New York Times reports. The devices are used to help manage patients who are taking warfarin. The newspaper said an analysis from the Public Citizen Health Research Group found that injuries associated with the INRatio devices are far higher than similar products. However, the FDA and INRatio’s developer (INRatio) have not publicly announced the apparent malfunction.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.